So R. Kim

Seoul, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Lower glucagon response and attenuated hepatic glucagon signaling in MASLD.

Lower glucagon response and attenuated hepatic glucagon signaling in MASLD.

Journal: Diabetes & metabolism

Published: June 17, 2026

Circulating β-Hydroxybutyrate in Glycemic Progression and Diabetic Cardiomyopathy: Adaptive Signal or Maladaptive Substrate?

Circulating β-Hydroxybutyrate in Glycemic Progression and Diabetic Cardiomyopathy: Adaptive Signal or Maladaptive Substrate?

Journal: International journal of molecular sciences

Published: March 20, 2026

Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy (EFFORT): A 24-week, randomized, open-label, multicenter trial.

Efficacy and safety of adding a fourth oral antidiabetic drug versus metformin dose escalation in patients with type 2 diabetes inadequately controlled on triple oral combination therapy (EFFORT): A 24-week, randomized, open-label, multicenter trial.

Journal: Diabetes, obesity & metabolism

Published: December 16, 2025

Protective Role of Serum β-Hydroxybutyrate in Early Diabetic Kidney Disease: A Longitudinal Study.

Protective Role of Serum β-Hydroxybutyrate in Early Diabetic Kidney Disease: A Longitudinal Study.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: September 01, 2025

Ketone Body Induction: Insights into Metabolic Disease Management.

Ketone Body Induction: Insights into Metabolic Disease Management.

Journal: Biomedicines

Published: April 30, 2025

Association of Preserved-Ratio Impaired Spirometry (PRISm) with All-Cause Mortality: A Longitudinal Cohort Study.

Association of Preserved-Ratio Impaired Spirometry (PRISm) with All-Cause Mortality: A Longitudinal Cohort Study.

Journal: Annals of the American Thoracic Society

Published: November 12, 2024

Short Term Isocaloric Ketogenic Diet Modulates NLRP3 Inflammasome Via B-hydroxybutyrate and Fibroblast Growth Factor 21.

Short Term Isocaloric Ketogenic Diet Modulates NLRP3 Inflammasome Via B-hydroxybutyrate and Fibroblast Growth Factor 21.

Journal: Frontiers in immunology

Published: December 26, 2021

SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease.

SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease.

Journal: Nature communications

Published: January 28, 2019

High serum CRP influences myocardial miRNA profiles in ischemia-reperfusion injury of rat heart.

High serum CRP influences myocardial miRNA profiles in ischemia-reperfusion injury of rat heart.

Journal: PloS one

Published: December 25, 2018

Sodium-glucose cotransporter 2 inhibitors regulate ketone body metabolism via inter-organ crosstalk.

Sodium-glucose cotransporter 2 inhibitors regulate ketone body metabolism via inter-organ crosstalk.

Journal: Diabetes, obesity & metabolism

Published: August 01, 2018

Senescent T Cells Predict the Development of Hyperglycemia in Humans.

Senescent T Cells Predict the Development of Hyperglycemia in Humans.

Journal: Diabetes

Published: October 07, 2017

The Relationship between Increases in Morning Spot Urinary Glucose Excretion and Decreases in HbA1C in Patients with Type 2 Diabetes After Taking an SGLT2 Inhibitor: A Retrospective, Longitudinal Study.

The Relationship between Increases in Morning Spot Urinary Glucose Excretion and Decreases in HbA1C in Patients with Type 2 Diabetes After Taking an SGLT2 Inhibitor: A Retrospective, Longitudinal Study.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: February 06, 2017

Showing 1-12 of 20

Last Updated: 09/26/2026